Cardiorenal disease development under chronic renin–angiotensin–aldosterone system suppression

• Published in: Journal of the renin-angiotensin-aldosterone system Vol. 13; no. 1; pp. 217 - 219
• Main Authors: Sarafidis, Pantelis A, Ruilope, Luis M
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.03.2012
• Subjects: Angiotensin Receptor Antagonists - adverse effects; Angiotensin-Converting Enzyme Inhibitors - adverse effects; Cardiovascular Diseases - chemically induced; Humans; Kidney Diseases - chemically induced; Renin-Angiotensin System - drug effects; Risk Factors

Drugs suppressing the renin-angiotensin-aldosterone system (RAAS) are now widely used to treat patients all along the cardiorenal continuum. It supposes that many patients, in particular those with arterial hypertension are treated with converting-enzyme inhibitors and angiotensin receptor blockers...